Search

is missing (Quiz)

This is a rare case of a patient with a double-layered lateral meniscus, undergoing surgical treatment. A 17-year-old woman who was a member of a volleyball club had a two-year history of right knee pain with episodes of locking, although she had no history of trauma. She was referred to our hospital because her condition did not improve after conservative treatment. On presentation to the hospital, she had full range of motion in the right knee. McMurray’s test revealed no clicks; however, it produced pain in the lateral part. Plain radiography revealed no abnormal findings, whereas magnetic resonance imaging showed high signal in the posterior segment of the lateral meniscus and an increase in its volume. Arthroscopic findings showed an accessory meniscus with a flat surface overlying a normal-sized lateral meniscus. It was firmly connected to the posterior root and middle segment of the lower normal meniscus. The accessory meniscus was markedly mobile as revealed by probing. The patient was diagnosed with double-layered lateral meniscus and underwent resection of the accessory meniscus. Postoperatively, she initiated strengthening of muscles and range of motion training without weight-bearing restrictions. Two months postoperatively, she had completely recovered and participated in volleyball practices. In the last follow-up at 18 months, she had no restrictions in daily or sports activities.

Loss-of-function mutations of filaggrin (FLG) gene (FLG) are the strongest known genetic risk factor for atopic dermatitis (AD). It is still debatable how FLG gene mutations and the resulting abnormal amount of FLG protein contribute to skin barrier function and symptoms of AD. In this study, we examined the effects of loss-of-function mutations of FLG gene on the severity of skin lesions and skin barrier function in 55 patients with AD by evaluating eight patients with AD with FLG gene mutations and 47 patients with AD without mutations. The results showed that the FLG gene mutation did not affect the duration of AD, severity of AD, degree of local inflammatory symptoms, skin water content and trans-epidermal water loss of the lesions. Next, in these eight mutation carriers and the 47 non-carriers, stratum corneum was collected from the three site of skin lesions using tape-stripping method, and the amounts of FLG protein and total amino acid contained in the stratum corneum was measured to investigate the effect of the FLG gene mutation on the amount of FLG gene product in the local lesion. FLG abnormalities had little effect on FLG protein and total amino acid content in the stratum corneum in the lesional skin. The amount of the FLG products, especially amino acids derived from FLG, in the stratum corneum of AD lesional skin is influenced by development of dermatitis. The results obtained from this study supports that the activation of Th2-dominant inflammatory cells, together with FLG abnormality, plays a role in suppressing the production of FLG in skin lesions.